Page last updated: 2024-08-23

ethylketocyclazocine and Kahler Disease

ethylketocyclazocine has been researched along with Kahler Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bakogeorgou, E; Castanas, E; Dimitriou, H; Hatzoglou, A; Kampa, M; Vassou, D	1

Other Studies

1 other study(ies) available for ethylketocyclazocine and Kahler Disease

Article	Year
Opioids modulate constitutive B-lymphocyte secretion. International immunopharmacology, 2008, Volume: 8, Issue:5 Topics: Analgesics, Opioid; Antigens, CD19; B-Lymphocytes; Caseins; Cell Line; Cytokines; Dose-Response Relationship, Drug; Ethylketocyclazocine; Humans; Immunoglobulins; In Vitro Techniques; Interleukins; Multiple Myeloma; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Phosphorylation; Receptors, Opioid, kappa; Receptors, Opioid, mu; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction	2008

Article

Year

Opioids modulate constitutive B-lymphocyte secretion.

International immunopharmacology, 2008, Volume: 8, Issue:5

Topics: Analgesics, Opioid; Antigens, CD19; B-Lymphocytes; Caseins; Cell Line; Cytokines; Dose-Response Relationship, Drug; Ethylketocyclazocine; Humans; Immunoglobulins; In Vitro Techniques; Interleukins; Multiple Myeloma; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Phosphorylation; Receptors, Opioid, kappa; Receptors, Opioid, mu; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction

2008